首页> 美国卫生研究院文献>other >Differential Fmo3 Gene Expression in Various Liver Injury Models Involving Hepatic Oxidative Stress in Mice
【2h】

Differential Fmo3 Gene Expression in Various Liver Injury Models Involving Hepatic Oxidative Stress in Mice

机译:在涉及肝氧化应激的小鼠各种肝损伤模型中差异Fmo3基因表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Flavin-containing monooxygenase-3 (FMO3) catalyzes metabolic reactions similar to cytochrome P450 monooxygenase however, most metabolites of FMO3 are considered non-toxic. Recent findings in our laboratory demonstrated Fmo3gene induction following toxic acetaminophen (APAP) treatment in mice.The goal of this study was to evaluate Fmo3gene expression in diverseother mouse models of hepatic oxidative stress and injury. Fmo3 gene regulation by Nrf2 was also investigated using Nrf2 knockout (Nrf2 KO) mice. In our studies, male C57BL/6J mice were treated with toxic dosesof hepatotoxicants or underwent bile duct ligation (BDL, 10d). Hepatotoxicants included APAP (400 mg/kg, 24 to 72h), alpha-naphthylisothiocyanate (ANIT; 50 mg/kg, 2 to 48h), carbontetrachloride (CCl4;10 or 30 μL/kg, 24 and 48h) and allyl alcohol (AlOH; 30 or 60 mg/kg, 6 and 24h). Because oxidative stress activates nuclear factor (erythroid-derived 2)-like 2 (Nrf2), additional studies investigated Fmo3 gene regulation by Nrf2 using Nrf2 knockout (Nrf2 KO) mice. At appropriate time-points, blood and liver samples were collected for assessment of plasma alanine aminotransferase (ALT) activity, plasma and hepatic bile acid levels, as well as liver Fmo3 mRNA and protein expression. Fmo3 mRNA expression increased significantly by 43-fold at 12h after ANIT treatment,and this increase translates to a 4-fold change in protein levels. BDL also increased Fmo3 mRNA expression by 1899-fold, but with no change in protein levels. Treatment of mice with CCl4decreased liver Fmo3gene expression, whileno change in expression was detected with AlOH treatment. Nrf2 KO mice are more susceptible to APAP (400 mg/kg, 72h) treatment compared to their wild-type (WT) counterparts, which is evidenced by greater plasma ALT activity. Fmo3 mRNA and protein expression increased in Nrf2 KO mice after APAP treatment. Collectively, not all hepatotoxicantsthat produce oxidative stress alter Fmo3gene expression. Along with APAP, toxic ANIT treatment in mice markedly increasedFmo3 gene expression. While BDL increased Fmo3 mRNA expression, protein level did not change. The discrepancy with Fmo3 induction in cholestatic models, ANIT and BDL, is not entirely clear. Results from Nrf2 KO mice with APAP suggest that the transcriptional regulation of Fmo3 during liver injury may not involve Nrf2.
机译:含黄素的单加氧酶-3(FMO3)催化类似于细胞色素P450单加氧酶的代谢反应,但是,大多数FMO3代谢产物被认为是无毒的。我们实验室的最新发现表明,对小鼠进行了有毒的对乙酰氨基酚(APAP)处理后,Fmo3基因的诱导。本研究的目的是评估在其他多种肝氧化应激和损伤模型中Fmo3基因的表达。还使用Nrf2基因敲除(Nrf2 KO)小鼠研究了Nrf2对Fmo3基因的调控。在我们的研究中,对雄性C57BL / 6J小鼠进行了毒性剂量的肝毒性治疗或进行了胆管结扎(BDL,10天)。肝毒性药物包括APAP(400 mg / kg,24至72h),α-萘基异硫氰酸酯(ANIT; 50 mg / kg,2至48h),四氯化碳(CCl4; 10或30μL/ kg,24和48h)和烯丙醇(AlOH ; 30或60 mg / kg,6和24h)。由于氧化应激会激活核因子(类胡萝卜素衍生的2)样2(Nrf2),因此其他研究使用Nrf2基因敲除(Nrf2 KO)小鼠研究了Nrf2对Fmo3基因的调控。在适当的时间点,收集血液和肝脏样品以评估血浆丙氨酸氨基转移酶(ALT)活性,血浆和肝胆汁酸水平以及肝脏Fmo3 mRNA和蛋白质表达。 FIT3 mRNA表达在ANIT治疗后12h显着增加了43倍,并且这种增加转化为蛋白质水平的4倍变化。 BDL还使Fmo3 mRNA表达增加了1899倍,但蛋白质水平没有变化。用CCl4处理的小鼠肝脏Fmo3基因表达降低,而用AlOH处理则未发现表达变化。与野生型(WT)相比,Nrf2 KO小鼠对APAP(400 mg / kg,72h)的治疗更敏感,这可通过更高的血浆ALT活性来证明。 APAP治疗后,Nrf2 KO小鼠中Fmo3 mRNA和蛋白表达增加。集体地,并不是所有产生氧化应激的肝毒性药物都会改变Fmo3基因的表达。与APAP一起,对小鼠进行的有毒ANIT治疗显着提高了Fmo3基因表达。虽然BDL增加了Fmo3 mRNA表达,但蛋白质水平没有变化。在胆汁淤积模型(ANIT和BDL)中,Fmo3诱导的差异尚不完全清楚。 Nrf2 KO小鼠APAP的结果表明,肝损伤期间Fmo3的转录调控可能不涉及Nrf2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号